Ballentine Partners’s Archrock AROC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$423K Buy
10,388
+402
+4% +$14.8K 0.01% 634
2026
Q1
$348K Buy
9,986
+5
+0.1% +$160 ﹤0.01% 671
2025
Q4
$260K Sell
9,981
-243
-2% -$6.04K ﹤0.01% 792
2025
Q3
$269K Sell
10,224
-28
-0.3% -$675 ﹤0.01% 778
2025
Q2
$255K Buy
10,252
+119
+1% +$2.92K ﹤0.01% 765
2025
Q1
$266K Buy
10,133
+575
+6% +$15.5K ﹤0.01% 670
2024
Q4
$238K Buy
+9,558
New +$221K ﹤0.01% 706
2020
Q1
Sell
-10,175
Closed -$102K 347
2019
Q4
$102K Buy
+10,175
New +$94.9K ﹤0.01% 401

Other funds holding AROC

Ballentine Partners's AROC Position: Q2 2026 in Review

Ballentine Partners increased its Archrock (AROC) stake by 4% in Q2 2026, buying an estimated $14.8K and bringing the position to 10,388 shares worth $423K. The position accounts for 0.01% of the portfolio, ranked #634.

Ballentine Partners first reported a position in AROC in Q4 2019 and has held it in 8 quarters since. 47 funds tracked by Wall St. Rank hold AROC as of Q2 2026.

  • Ballentine Partners held 10,388 shares of Archrock worth $423K as of Q2 2026.
  • Ballentine Partners bought 402 Archrock shares in Q2 2026, an estimated $14.8K.
  • Archrock made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #634 holding.
  • Ballentine Partners first reported a position in Archrock in Q4 2019 and has held it in 8 quarters since.
  • 47 funds tracked by Wall St. Rank held Archrock as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.